About
Optina Dx develops a retinal imaging platform combined with FDA 510(k) cleared hyperspectral camera technology and AI to support faster and more accurate diagnosis and management of Age-Related Macular Degeneration and other retinal diseases.
Explore Optina Dx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.